Palvella Therapeutics PVLA
NASDAQ PVLA
$132.47 -0.26 (-0.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

Palvella Therapeutics (PVLA) Cash & Current Investments (2013 - 2026)

Updated

Palvella Therapeutics (PVLA) recorded Cash & Current Investments of $250.6 million in Q2 2026, up 255.8% from $70.43 million a year earlier but down 4.3% from the prior quarter.

Analysis

Palvella Therapeutics (PVLA) Cash & Current Investments (2013 - 2026) Analysis & Trends

At the end of FY2025, Palvella Therapeutics reported Cash & Current Investments of $57.98 million, down 30.6% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of -3.8% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $83.6 million in FY2024 (+216.7%), $26.4 million in FY2023 (-55.4%), $59.2 million in FY2022 (-49.7%) and $117.76 million in FY2021 (+67.2%).
  • Quarterly Cash & Current Investments has ranged from $19.1 million in Q1 2024 to $261.85 million in Q1 2026 over the past five years.
  • On a year-over-year basis, Cash & Current Investments rose in six of the last eight quarters, with growth averaging 176.6%.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 295.9% in Q1 2025, against a decline of 64.1% in Q2 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $261.85 million (Q1 2026), $57.98 million (Q4 2025) and $63.57 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Palvella Therapeutics 1.91 Bn 1.66 Bn - 250.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 250.60 Mn
Mar 31, 2026 261.85 Mn
Dec 31, 2025 57.98 Mn
Sep 30, 2025 63.57 Mn
Jun 30, 2025 70.43 Mn
Mar 31, 2025 75.63 Mn
Dec 31, 2024 83.60 Mn
Sep 30, 2024 19.40 Mn
Jun 30, 2024 19.70 Mn
Mar 31, 2024 19.10 Mn
Dec 31, 2023 26.40 Mn
Sep 30, 2023 44.80 Mn
Jun 30, 2023 54.90 Mn
Mar 31, 2023 48.40 Mn
Dec 31, 2022 59.20 Mn
Sep 30, 2022 69.80 Mn
Jun 30, 2022 80.94 Mn
Mar 31, 2022 100.27 Mn
Dec 31, 2021 117.76 Mn
Sep 30, 2021 125.05 Mn
API Access

Palvella Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PVLA&period=max&api_key=YOUR_API_KEY